✦ LIBER ✦

129 Molecular epidemiology of the longitudinal course of the Pseudomonas aeruginosa infection in Cystic Fibrosis

✍ Scribed by N. Cramer; L. Wiehlmann; G. Wagner; B. Tümmler

Book ID: 118640742
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 125 KB
Volume: 5
Category: Article
ISSN: 1569-1993
DOI: 10.1016/s1569-1993(06)80113-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epidemiology of chronic Pseudomonas aeru

Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis

✍ Burçin Şener; Özgen Köseoğlu; Uğur Özçelik; Tan∣l Kocagöz; Ayfer Günalp 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 338 KB

Epidemiology of first/new Pseudomonas ae

Epidemiology of first/new Pseudomonas aeruginosa infection in cystic fibrosis patients

✍ L. Zavataro; G. Taccetti; L. Cariani; N. Ravenni; G. Braccini; S. Bresci; F. Tre 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Epidemiology of Pseudomonas aeruginosa i

Epidemiology of Pseudomonas aeruginosa infection in cystic fibrosis and the use of strain genotyping

✍ D.L. Smith; E.G. Smith; L.B. Gumery; D.E. Stableforth; L.M. Dalla Costa; T.L. Pi 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 407 KB

The pathogenesis of Pseudomonas aerugino

The pathogenesis of Pseudomonas aeruginosa lung infections in cystic fibrosis

✍ K. GRIMWOOD 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 871 KB

EPIDEMIOLOGY OF PSEUDOMONAS AERUGINOSA I

EPIDEMIOLOGY OF PSEUDOMONAS AERUGINOSA INFECTION IN PATIENTS TREATED AT A CYSTIC FIBROSIS CENTRE

✍ HøIby, Niels ;Rosendal, Kirsten 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) ⚖ 545 KB

Changing Epidemiology of Pseudomonas aer

Changing Epidemiology of Pseudomonas aeruginosa Infection in Danish Cystic Fibrosis Patients (1974–1995)

✍ Birgitte Frederiksen; Christian Koch; Niels Høiby 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 300 KB

Recurrent and chronic lower airway infection with Pseudomonas aeruginosa (PA) is an important component of cystic fibrosis (CF) pulmonary disease. Different modes of treatment and control of CF patients have been introduced at the Copenhagen CF Centre over the past 20 years and have been associated